The rising demand for personalized medicine research has generated a need for relatively more reliable cell models and cellular material leading to introduction of 3D cell culture technology. The technology aids in carrying out more effective drug discovery and toxicology testing as well as cancer research as traditional 2D cell culture may not accurately mimic the 3D environment in which cancer cells reside. These start-to-end cell culture solutions can save money and time along with improving end results.

The 3D cell culture market growth is mainly driven by increased oncology drug discovery studies, rising investments in the field, favourable government policies and support, and the use of 3D cell cultures as an alternative to animal testing in toxicology studies. The technology has major application in the area of cancer drug development as use of 3D cell culture enhances physiological relevance of cell-based assays giving meaningful results.

Various researches are also focusing on using advanced 3D cell culture models to test efficiency and effect of the new cancer drug. For instance, in March 2018, Institute for Research in Biomedicine (IRB), Barcelona developed a mouse model to study immune system response in advanced human colon cancer using AMSBIO’s 3D organoid culture technology. Such developments are set to further boost the demand for 3D cell culture technology.

Various prominent players operating in the 3D cell culture market include 3D Biotek, AMSBIO, Corning Lifesciences, Synthecon, MilliporeSigma, Thermo Fisher Scientific, and Nanofiber Solutions among others.

The global 3D cell culture market has been categorized based on technology, application, and key geographies. Technology segmentation of market includes Scaffold-free, Scaffold-based, and others. Scaffold-free segment is further sub-segmented into Low Attachment Surfaces, Hanging Drop Method, 3D Petri Dishes, and 3D Bioreactors. While Scaffold-based market is sub-segmented into Hydrogels, Porous Scaffolds, Fibrous Scaffolds, and Micropatterned Surfaces. The global 3D cell culture market is segmented into Cancer Research, Tissue Engineering, Drug Discovery & Toxicology, and Stem Cell Research.

This research report on 3D cell culture market provides in-depth analysis of the global 3D cell culture market based on technology, application, and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for 3D cell culture market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent development in the market.

Key questions answered in this research report:
1. At what pace is 3D cell culture market growing? What will be growth trend in future?
2. What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
3. What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the 3D cell culture market?
4. What are the various product/ technology areas and how they are poised to grow?
5. What are the various application areas and how they are poised to grow?

The global 3D cell culture market is segmented on the basis of technology, application, and geography:

Global 3D Cell Culture Market by Technology
· Scaffold-free
o Low Attachment Surfaces
o Hanging Drop Method
o 3D Petri Dishes
o 3D Bioreactors

· Scaffold-based
o Hydrogels
o Porous Scaffolds
o Fibrous Scaffolds
o Micropatterned Surfaces
· Others

Global 3D Cell Culture Market by Application
· Drug Discovery & Toxicology
· Cancer Research
· Stem Cell Research
· Tissue Engineering

Global 3D Cell Culture Market by Geography
· North America
· Asia-Pacific
· Europe
· RoW

Global 3D Cell Culture Market Competitive Landscape
· Major Players and their Key Strategies
· New product launches
· Mergers and acquisitions
· Collaborations, partnerships, agreements and joint venture